UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049310
Receipt number R000056156
Scientific Title Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled study
Date of disclosure of the study information 2022/11/01
Last modified on 2023/05/17 09:46:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Lemborexant on insomnia in patients with schizophrenia
: A randomized controlled study

Acronym

Effects of Lemborexant on insomnia in patients with schizophrenia
: A randomized controlled study

Scientific Title

Effects of Lemborexant on insomnia in patients with schizophrenia
: A randomized controlled study

Scientific Title:Acronym

Effects of Lemborexant on insomnia in patients with schizophrenia
: A randomized controlled study

Region

Japan


Condition

Condition

Insomnia in patients with schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To objectively investigate the effect of Lemborexant on insomnia in schizophrenic patients.

Basic objectives2

Others

Basic objectives -Others

To evaluate the association between nighttime blood orexin A levels and the efficacy of Lenvorexant

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Sleep variables obtained from actigraphs. Comparison between the 7-day pre-observation period and the 7th to 13th days after the intervention.

Key secondary outcomes

Association between change from baseline in sleep variables obtained from Actigraphs and blood orexin A levels at night.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of 5 mg of Lemborexant for 14 days

Interventions/Control_2

14 days of placebo administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1.Satisfy DSM5 diagnostic criteria for schizophrenia
2. Being treated in Kurita hospital
3.Those aged between 20 and 70.
4.Satisfy DSM5 diagnostic criteria for insomnia.
5.Using one or less benzodiazepines.
6.Not taking orexin receptor antagonists.

Key exclusion criteria

1.Coexisting with mood disorder, anxiety disorder, drug addiction, or personality disorder.
2.Suffering from serious physical diseases such as cerebrovascular disease, heart disease, renal dysfunction, and neurological disease.
3.Coexisting with other sleep disorders such as hypersomnia, sleep-related breathing disorders, circadian rhythm sleep disorders, parasomnia, and sleep-related movement disorders.
4.Actigraphy cannot be performed safely.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Arai

Organization

Shinshu University School of Medicine

Division name

Department of Psychiatry

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto-City, Nagano, Japan,

TEL

+81-263-37-2638

Email

y-arai@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Arai

Organization

Kurita Hospital

Division name

Department of Psychiatry

Zip code

380-0921

Address

695 Kurita Nagano-City Nagano, Japan, 380-0921

TEL

+81-262-26-1311

Homepage URL


Email

y-arai@shinshu-u.ac.jp


Sponsor or person

Institute

Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921

Institute

Department

Personal name



Funding Source

Organization

Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Psychiatry, Kurita Hospital

Address

695 Kurita Nagano-City Nagano, Japan, 380-0921

Tel

+81-262-26-1311

Email

19hm101k@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

栗田病院(長野県)


Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2022 Year 10 Month 25 Day

Date of IRB

2022 Year 10 Month 25 Day

Anticipated trial start date

2022 Year 10 Month 25 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 25 Day

Last modified on

2023 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056156


Research Plan
Registered date File name
2023/04/29 症例登録票.docx

Research case data specifications
Registered date File name
2023/04/29 症例報告.xlsx

Research case data
Registered date File name